Alerts will be sent to your verified email
Verify Email
OXYGENTAPH
|
Oxygenta Pharma
|
Ambalal Sarabhai Ent
|
Aarey Drugs & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
15.02 % | 19.11 % | 5.07 % |
|
5yr average Equity Multiplier
|
-1.71 | 2.07 | 2.28 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 0.75 | 1.56 |
|
5yr Avg Net Profit Margin
|
-10.07 % | 10.89 % | 1.44 % |
|
Price to Book
|
0.0 | 1.75 | 1.79 |
|
P/E
|
0.0 | 19.14 | 59.59 |
|
5yr Avg Cash Conversion Cycle
|
-21.7 Days | -37.53 Days | 77.34 Days |
|
Inventory Days
|
80.38 Days | 33.51 Days | 20.31 Days |
|
Days Receivable
|
20.8 Days | 63.69 Days | 172.65 Days |
|
Days Payable
|
154.17 Days | 147.98 Days | 98.9 Days |
|
5yr Average Interest Coverage Ratio
|
-3.16 | 9.88 | 4.14 |
|
5yr Avg ROCE
|
-3.19 % | 24.01 % | 8.93 % |
|
5yr Avg Operating Profit Margin
|
-9.3 % | 5.29 % | 1.54 % |
|
5 yr average Debt to Equity
|
-1.91 | 0.32 | 0.21 |
|
5yr CAGR Net Profit
|
n/a | -30.01 % | -4.17 % |
|
5yr Average Return on Assets
|
-6.87 % | 8.69 % | 2.26 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.95 % | 31.35 % | 44.8 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
45.62 % | 0.59 % | -5.23 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.04 % | 0.0 | 0.0 |
|
Oxygenta Pharma
|
Ambalal Sarabhai Ent
|
Aarey Drugs & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|